Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience.

Autor: Billiet, T.1, Cleynen, I.1, Ballet, V.2, Ferrante, M.1,2, Van Assche, G.1,2, Gils, A.3, Vermeire, S.1,2
Zdroj: Alimentary Pharmacology & Therapeutics. Oct2016, Vol. 44 Issue 7, p673-683. 11p. 1 Diagram, 3 Charts, 2 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje